Moreover, the protein kinase B/mammalian target of rapamycin (AKT/mTOR) pathway is activated in part through HIFs, and the pharmacological inhibition of mTOR with rapamycin inhibits melanoma growth in mice [66]. This evidence concerns the gene AKT1 and melanoma.